A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

NCT07581951 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

MASH - Metabolic Dysfunction-Associated Steatohepatitis
NASH (Non-Alcoholic Steatohepatitis)

Interventions

DRUG: HSK31679
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.